Abstract
Since the onset of the novel coronavirus (COVID-19) global health crisis, there has been an unprecedented change to the field of spinal surgery. Comprehensive protocols and algorithms have been implemented globally to maximize available bed space, conserve personal protective equipment, and to minimize exposure. This has resulted in a sharp decline in elective spinal surgery and placed an undue burden on the spinal industry. As the landscape of elective surgery changes, this paper looks to analyze the effects the COVID-19 pandemic has and will have on spinal instrumentation companies, surgeons, and the spinal industry. Changes in government policies, patient care, financial markets, and distribution have all presented an unprecedented strain on spinal instrumentation companies. A narrative literature review was performed using published literature from PubMed. Due to the socioeconomic and financial nature of this review, data collection from financial references was also obtained and cited. With significant financial losses reported throughout the spinal industry and medical field, this paper discusses managing the COVID-19 pandemic and the future prospectus moving forward. As the pandemic continues to unfold, it remains difficult to predict the exact timing for broad resumption of elective medical procedures, and the extent to which the pandemic will affect the industry. Preparation aimed at facilitating efficient resource allocation and communication among surgeons, surgical instrumentation representatives and hospital leadership is essential as we transition forward and reestablish normalcy under the new constraints of COVID-19.
Highlights
BackgroundNovel coronavirus 2019 (COVID-19) was declared an emergency of public concern by the World Health Organization on January 30, 2020, and was declared a pandemic on March 11, 2020 [1]
As the landscape of elective surgery changes, this paper looks to analyze the effects the COVID-19 pandemic has and will have on spinal instrumentation companies, surgeons, and the spinal industry
As the landscape of elective surgery changes, this paper looks to analyze the effects this pandemic has and will have on spinal instrumentation companies, both socially and financially
Summary
Novel coronavirus 2019 (COVID-19) was declared an emergency of public concern by the World Health Organization on January 30, 2020, and was declared a pandemic on March 11, 2020 [1]. As a result of restrictive measures in response to the pandemic, operations for companies in the spine instrumentation market have been adversely affected Several of these companies have products that are sensitive to the reductions in elective medical procedures, which were suspended in diverse markets during the first quarter of 2020, negatively impacting business, cash flows, and financial conditions. As the pandemic limits the surgeon’s ability to offer surgical intervention to patients, the use of conservative treatment will be emphasized This serves as a limitation in some facets, it is an opportunity for surgeons to weigh the effectiveness of spinal instrumentation as the demand has increased in recent years. With the structure and resources geared towards maximizing surgical efficiency, it seems spinal surgery in ambulatory surgical centers has a bright future ahead
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
